Cargando…
Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
Hereditary breast and ovarian cancer syndrome (HBOC) is most frequently caused by mutations in BRCA1 or BRCA2 (in short, BRCA) genes. The incidence of hereditary breast and ovarian cancer in relatives of BRCA mutation carriers who test negative for the familial mutation (non-carriers) may be increas...
Autores principales: | Mitchell, Rachel, Buckingham, Lela, Cobleigh, Melody, Rotmensch, Jacob, Burgess, Kelly, Usha, Lydia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901986/ https://www.ncbi.nlm.nih.gov/pubmed/29659587 http://dx.doi.org/10.1371/journal.pone.0195497 |
Ejemplares similares
-
Somatic variants of potential clinical significance in the tumors of BRCA phenocopies
por: Buckingham, Lela, et al.
Publicado: (2019) -
PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer
por: Annunziata, Christina M, et al.
Publicado: (2010) -
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
por: Zaaijer, Leendert H, et al.
Publicado: (2016) -
Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers
por: Wineland, Dylane, et al.
Publicado: (2023) -
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
por: McKinley, Joanne M, et al.
Publicado: (2007)